193 related articles for article (PubMed ID: 26181715)
21. Pharmacologic treatment of atrophic age-related macular degeneration.
Mata NL; Vogel R
Curr Opin Ophthalmol; 2010 May; 21(3):190-6. PubMed ID: 20216419
[TBL] [Abstract][Full Text] [Related]
22. Complement modulation in the retinal pigment epithelium rescues photoreceptor degeneration in a mouse model of Stargardt disease.
Lenis TL; Sarfare S; Jiang Z; Lloyd MB; Bok D; Radu RA
Proc Natl Acad Sci U S A; 2017 Apr; 114(15):3987-3992. PubMed ID: 28348233
[TBL] [Abstract][Full Text] [Related]
23. Multimodal imaging and multifocal electroretinography demonstrate autosomal recessive Stargardt disease may present like occult macular dystrophy.
Sisk RA; Leng T
Retina; 2014 Aug; 34(8):1567-75. PubMed ID: 24743636
[TBL] [Abstract][Full Text] [Related]
24. Automated segmentation and feature discovery of age-related macular degeneration and Stargardt disease via self-attended neural networks.
Wang Z; Sadda SR; Lee A; Hu ZJ
Sci Rep; 2022 Aug; 12(1):14565. PubMed ID: 36028647
[TBL] [Abstract][Full Text] [Related]
25. Choroidal Thickness in Eyes With Central Geographic Atrophy Secondary to Stargardt Disease and Age-Related Macular Degeneration.
Nunes RP; Rosa PR; Giani A; Goldhardt R; Thomas B; Garcia Filho CA; Gregori G; Feuer W; Lam BL; Staurenghi G; Rosenfeld PJ
Ophthalmic Surg Lasers Imaging Retina; 2015 Sep; 46(8):814-22. PubMed ID: 26431296
[TBL] [Abstract][Full Text] [Related]
26. Choroidal Flow Signal in Late-Onset Stargardt Disease and Age-Related Macular Degeneration: An OCT-Angiography Study.
Müller PL; Pfau M; Möller PT; Nadal J; Schmid M; Lindner M; de Sisternes L; Stöhr H; Weber BHF; Neuhaus C; Herrmann P; Schmitz-Valckenberg S; Holz FG; Fleckenstein M
Invest Ophthalmol Vis Sci; 2018 Mar; 59(4):AMD122-AMD131. PubMed ID: 30140905
[TBL] [Abstract][Full Text] [Related]
27. Novel therapeutics for Stargardt disease.
Lu LJ; Liu J; Adelman RA
Graefes Arch Clin Exp Ophthalmol; 2017 Jun; 255(6):1057-1062. PubMed ID: 28285324
[TBL] [Abstract][Full Text] [Related]
28. Treatments for dry age-related macular degeneration and Stargardt disease: a systematic review.
Waugh N; Loveman E; Colquitt J; Royle P; Yeong JL; Hoad G; Lois N
Health Technol Assess; 2018 May; 22(27):1-168. PubMed ID: 29846169
[TBL] [Abstract][Full Text] [Related]
29. Transgenic Mice Overexpressing Serum Retinol-Binding Protein Develop Progressive Retinal Degeneration through a Retinoid-Independent Mechanism.
Du M; Otalora L; Martin AA; Moiseyev G; Vanlandingham P; Wang Q; Farjo R; Yeganeh A; Quiambao A; Farjo KM
Mol Cell Biol; 2015 Aug; 35(16):2771-89. PubMed ID: 26055327
[TBL] [Abstract][Full Text] [Related]
30. Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD).
Ramkumar HL; Zhang J; Chan CC
Prog Retin Eye Res; 2010 May; 29(3):169-90. PubMed ID: 20206286
[TBL] [Abstract][Full Text] [Related]
31. Dark Atrophy: An Optical Coherence Tomography Angiography Study.
Pellegrini M; Acquistapace A; Oldani M; Cereda MG; Giani A; Cozzi M; Staurenghi G
Ophthalmology; 2016 Sep; 123(9):1879-86. PubMed ID: 27448830
[TBL] [Abstract][Full Text] [Related]
32. Visual cycle modulators versus placebo or observation for the prevention and treatment of geographic atrophy due to age-related macular degeneration.
Yeong JL; Loveman E; Colquitt JL; Royle P; Waugh N; Lois N
Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013154. PubMed ID: 33331670
[TBL] [Abstract][Full Text] [Related]
33. Early-onset stargardt disease: phenotypic and genotypic characteristics.
Lambertus S; van Huet RA; Bax NM; Hoefsloot LH; Cremers FP; Boon CJ; Klevering BJ; Hoyng CB
Ophthalmology; 2015 Feb; 122(2):335-44. PubMed ID: 25444351
[TBL] [Abstract][Full Text] [Related]
34. Dry Age-Related Macular Degeneration Pharmacology.
Wright CB; Ambati J
Handb Exp Pharmacol; 2017; 242():321-336. PubMed ID: 27900609
[TBL] [Abstract][Full Text] [Related]
35. Time-resolved fluorescence resonance energy transfer and surface plasmon resonance-based assays for retinoid and transthyretin binding to retinol-binding protein 4.
Sharif O; Hu H; Klock H; Hampton EN; Nigoghossian E; Knuth MW; Matzen J; Anderson P; Trager R; Uno T; Glynne RJ; Azarian SM; Caldwell JS; Brinker A
Anal Biochem; 2009 Sep; 392(2):162-8. PubMed ID: 19482004
[TBL] [Abstract][Full Text] [Related]
36. Defective lipid transport and biosynthesis in recessive and dominant Stargardt macular degeneration.
Molday RS; Zhang K
Prog Lipid Res; 2010 Oct; 49(4):476-92. PubMed ID: 20633576
[TBL] [Abstract][Full Text] [Related]
37. Progression of retinal pigment epithelial atrophy in stargardt disease.
McBain VA; Townend J; Lois N
Am J Ophthalmol; 2012 Jul; 154(1):146-54. PubMed ID: 22464366
[TBL] [Abstract][Full Text] [Related]
38. INSIGHTS INTO AUTOSOMAL DOMINANT STARGARDT-LIKE MACULAR DYSTROPHY THROUGH MULTIMODALITY DIAGNOSTIC IMAGING.
Palejwala NV; Gale MJ; Clark RF; Schlechter C; Weleber RG; Pennesi ME
Retina; 2016 Jan; 36(1):119-30. PubMed ID: 26110599
[TBL] [Abstract][Full Text] [Related]
39. Transgenic Mice Over-Expressing RBP4 Have RBP4-Dependent and Light-Independent Retinal Degeneration.
Du M; Phelps E; Balangue MJ; Dockins A; Moiseyev G; Shin Y; Kane S; Otalora L; Ma JX; Farjo R; Farjo KM
Invest Ophthalmol Vis Sci; 2017 Aug; 58(10):4375–4383. PubMed ID: 28813718
[TBL] [Abstract][Full Text] [Related]
40. Suprachoroidal Adipose Tissue-Derived Mesenchymal Stem Cell Implantation in Patients with Dry-Type Age-Related Macular Degeneration and Stargardt's Macular Dystrophy: 6-Month Follow-Up Results of a Phase 2 Study.
Oner A; Gonen ZB; Sevim DG; Smim Kahraman N; Unlu M
Cell Reprogram; 2018 Dec; 20(6):329-336. PubMed ID: 31251672
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
